NCT04362865View on ClinicalTrials.gov

Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

679

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

February 10, 2025

Study Completion Date

February 10, 2025

Conditions
COVID-19
Trial Locations (4)

20010

Medstar Washington Hospital Center, Washington D.C.

20832

Medstar Montgomery Medical Center, Olney

20892

National Institutes of Health Clinical Center, Bethesda

21237

Medstar Franklin Square Medical Center, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT04362865 - Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection | Biotech Hunter | Biotech Hunter